Pesquisar
Inventiva SA
IVAAdicionar à lista de desejos
3.260USD
-0.190-5.51%
Fechamento 09-23 16:00（ET）
770.13MValor de mercado
0.00P/L TTM
Sobre o Inventiva SA Empresa
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
Inventiva SA Perfil
Código da empresaIVA
Nome da EmpresaInventiva SA
Data de listagemFeb 15, 2017
CEOObenshain (Andrew)
Número de funcionários- -
Tipo de títulosDepository Receipt
Fim do ano fiscal- -
Endereço50 rue de Dijon
CidadeDAIX
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísFrance
Código postal21121
Telefone33380447500
Sitehttps://inventivapharma.com/
Código da empresaIVA
Data de listagemFeb 15, 2017
CEOObenshain (Andrew)
Executivos da empresa Inventiva SA
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Andre Turenne
Mr. Andre Turenne
Independent Director
Independent Director
--
--
Mr. Andrew Obenshain
Mr. Andrew Obenshain
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Christopher (Chris) Benecchi
Mr. Christopher (Chris) Benecchi
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Dr. Annick Schwebig, M.D.
Dr. Annick Schwebig, M.D.
Independent Director
Independent Director
--
--
Mr. Heinz Maeusli
Mr. Heinz Maeusli
Independent Director
Independent Director
--
--
Mr. Eric Duranson
Mr. Eric Duranson
General Counsel
General Counsel
--
--
Ms. Pascaline Clerc
Ms. Pascaline Clerc
Executive Vice President - Strategy and Corporate Affairs
Executive Vice President - Strategy and Corporate Affairs
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Andre Turenne
Mr. Andre Turenne
Independent Director
Independent Director
--
--
Mr. Andrew Obenshain
Mr. Andrew Obenshain
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Christopher (Chris) Benecchi
Mr. Christopher (Chris) Benecchi
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Inventiva SA?
Os cinco principais acionistas de Inventiva SA são: Mr. Andre Turenne
Quantas instituições possuem ações da Inventiva SA (IVA)?
Em 2026Q1, 63 instituições possuíam ações da Inventiva SA, com valor de mercado aproximado de 49.29M, representando 25.51% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 35581870.00.